Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2025-12-24 @ 2:50 PM
NCT ID:
NCT01699659
Eligibility Criteria:
Inclusion Criteria:
* Allergic rhinitis between 18 and 65 years old who have chosen to undergo immunotherapy.
Exclusion Criteria:
* No beta blocker use,
* no pregnancy,
* no systemic steroids,
* no severe asthma/copd,
* no severe collagen vascular disorders,
* no neoplastic or uncontrolled seizure activity,
* no previous anaphylaxis, no significant cardiovsacular disease.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01699659
Study Brief:
Protocol Section:
NCT01699659